Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R2VH
|
||||
Former ID |
DIB018571
|
||||
Drug Name |
2-oleoyl-LPA
|
||||
Synonyms |
2-acyl-1LPA; 2Acyl-LPA
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539953] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H41O7P
|
||||
InChI |
InChI=1S/C21H41O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(23)28-20(18-22)19-27-29(24,25)26/h9-10,20,22H,2-8,11-19H2,1H3,(H2,24,25,26)/b10-9-
|
||||
InChIKey |
ZOOLJLSXNRZLDH-KTKRTIGZSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Lysophosphatidic acid receptor Edg-2 | Target Info | Agonist | [525840] | |
Lysophosphatidate-3 receptor | Target Info | Agonist | [525840] | ||
LPA2 receptor | Target Info | Agonist | [525840] | ||
G protein-coupled receptor 35 | Target Info | Agonist | [530825] | ||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | LPA receptor mediated eventslysophospholipid_pathway:LPA receptor mediated events | ||||
References | |||||
Ref 525840 | Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett. 2000 Jul 28;478(1-2):159-65. | ||||
Ref 530825 | GPR35 is a novel lysophosphatidic acid receptor. Biochem Biophys Res Commun. 2010 Apr 30;395(2):232-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.